102 related articles for article (PubMed ID: 19227559)
1. Switching Combivir to Truvada keeps HIV undetectable, improves blood fats, fails to improve limb fat.
Proj Inf Perspect; 2008 Dec; (47):8. PubMed ID: 19227559
[No Abstract] [Full Text] [Related]
2. Two-once-daily fixed-dose NRTI combinations for HIV.
Med Lett Drugs Ther; 2005 Feb; 47(1203):19-20. PubMed ID: 15767973
[TBL] [Abstract][Full Text] [Related]
3. Truvada and Epivir are similar at suppressing HIV.
Proj Inf Perspect; 2009 Mar; (48):5-6. PubMed ID: 19492457
[No Abstract] [Full Text] [Related]
4. 144-week data released on Gilead's study 934.
AIDS Patient Care STDS; 2007 Aug; 21(8):603-4. PubMed ID: 17902243
[No Abstract] [Full Text] [Related]
5. A truvada hypersensitivity reaction simulating abacavir hypersensitivity.
de Perio MA; Gomez FJ; Frame PT; Fichtenbaum CJ
AIDS; 2007 Oct; 21(16):2252-3. PubMed ID: 18090057
[No Abstract] [Full Text] [Related]
6. Truvada intolerance.
Vemuri S; Bratberg J; Burke K; Skowron G
AIDS; 2007 Jan; 21(3):382-3. PubMed ID: 17255751
[No Abstract] [Full Text] [Related]
7. HIV study yields unexpected preliminary efficacy results.
Traynor K
Am J Health Syst Pharm; 2008 Apr; 65(8):686-8. PubMed ID: 18387889
[No Abstract] [Full Text] [Related]
8. Emtricitabine intolerance in treatment-experienced patients switched from lamivudine: a method of assessing toxicity.
Pollock K; Stebbing J; Bower M; Gazzard B; Nelson M
J Antimicrob Chemother; 2006 Jul; 58(1):227-8. PubMed ID: 16684800
[No Abstract] [Full Text] [Related]
9. Emtricitabine/tenofovir (Truvada) for HIV prophylaxis.
Coutinho B; Prasad R
Am Fam Physician; 2013 Oct; 88(8):535-40. PubMed ID: 24364575
[No Abstract] [Full Text] [Related]
10. Generic Truvada approved.
AIDS Patient Care STDS; 2009 May; 23(5):395. PubMed ID: 19422066
[No Abstract] [Full Text] [Related]
11. The Truvada wars.
Belluz J
BMJ; 2014 Jun; 348():g3811. PubMed ID: 24961949
[No Abstract] [Full Text] [Related]
12. New once-a-day drugs: Truvada and Epzicom.
Berger DS
Posit Aware; 2004; 15(6):38-9. PubMed ID: 15619773
[No Abstract] [Full Text] [Related]
13. FDA PrEPares to reduce risk of HIV infection with Truvada®.
Breeze S
Expert Rev Clin Pharmacol; 2012 Sep; 5(5):499. PubMed ID: 23272332
[No Abstract] [Full Text] [Related]
14. Early lipodystrophy occurring during post-exposure prophylaxis.
Spenatto N; Viraben R
Sex Transm Infect; 1998 Dec; 74(6):455. PubMed ID: 10195060
[No Abstract] [Full Text] [Related]
15. Another blue pill for sex: Preventing HIV with Truvada PrEP--already at a pharmacy near you.
Vázquez E
Posit Aware; 2011; 23(5):25-7. PubMed ID: 22563594
[No Abstract] [Full Text] [Related]
16. [New fixed combination for HIV therapy].
Krankenpfl J; 2005; 43(4-6):95. PubMed ID: 16171046
[No Abstract] [Full Text] [Related]
17. Minor emtricitabine intolerance in treatment-stable patients switched from tenofovir/lamivudine to a fixed-dose combination of tenofovir/emtricitabine (Truvada).
Palacios R; Terrón A; Hidalgo A; Rivero A; Santos J;
J Antimicrob Chemother; 2008 Feb; 61(2):462-3. PubMed ID: 18156608
[No Abstract] [Full Text] [Related]
18. Transmission. Company halts Truvada PrEP for women study.
AIDS Policy Law; 2011 Jun; 26(7):1. PubMed ID: 21735622
[No Abstract] [Full Text] [Related]
19. Treatment options for HIV, AIDS.
FDA Consum; 2004; 38(6):4. PubMed ID: 15675011
[No Abstract] [Full Text] [Related]
20. Lamivudine/zidovudine: paediatric indication. For certain HIV-infected children.
Prescrire Int; 2008 Dec; 17(98):228. PubMed ID: 19418647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
